Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582101 · ClinicalTrials.gov registry record · Phase 1
Family-Based HIV Prevention for Latinos
A Phase 1 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00582101 is a Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 80 participants.
The verdict
NCT00582101, a Phase 1 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The proposed project will develop and test an HIV prevention intervention for Latino families. This study will: 1. Conduct a pilot "run-through" of an adapted family-based intervention with three cohorts (about 24 families) to determine the feasibility, acceptability, and appropriateness for the target population. 2. Revise the family-based HIV prevention intervention based on the results of the pilot "run-through" and structured exit interviews. 3. Recruit and randomize 100 families into the Latino family-based HIV prevention intervention or a general health promotion condition. 4. Estimate the effect size of the Latino family-based HIV prevention intervention from assessment of changes in HIV-related sexual behavior and attitudes and parental monitoring/supervision over 6 months. Based on a thorough review of the literature, the following is anticipated: 1. The revised intervention will be feasible, acceptable, and appropriate for Latino families and will be enthusiastically received. 2. The family-based HIV prevention intervention will result in safer adolescent sexual behavior, greater change with regard to primary outcome measures of behavior (recent sexual activity, the number of unprotected sex acts, proportion of condom use, and intentions to use condoms), safer HIV-related attitudes, improved parent-child communication skills, and greater parental monitoring than the Latino families in the general health promotion condition.
Interventions
- BEHAVIORAL General Health Promotion
- BEHAVIORAL Family-Based HIV Prevention for Latinos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582101
The ClinicalTrials.gov registry entry for NCT00582101 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General Health Promotion is the first listed.
NCT00582101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582101 about?
NCT00582101 is a clinical study titled "Family-Based HIV Prevention for Latinos". The proposed project will develop and test an HIV prevention intervention for Latino families. This study will: 1. Conduct a pilot "run-through" of an adapted family-based intervention with three cohorts (about 24 families) to determine the feasibility, acceptability, and appropriateness for the ta...
What is the current status of trial NCT00582101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2007-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00582101?
The interventions under investigation include: General Health Promotion (BEHAVIORAL), Family-Based HIV Prevention for Latinos (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582101?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.